The following press release was issued in New Delhi on the 16th of December 2019. The author, Dr. Jacob Puliyel, MD, MRCP, M Phil, heads the pediatric department of St. Srephens Hospital in Delhi, India. Until recently, he was also a member of the National Technical Advisory Group on Immunization (NTAGI) of the government of […]
Anti-vaccination is expected consumer behaviour
By Jagannath Chatterjee How would you act if you have decided to buy a car? You would probably visit the car showrooms, talk to the salesmen, collect literature on the cars, visit other showrooms, search the internet, talk to people who have purchased cars, exchange ideas with your friends, talk to the mechanics, and find […]
AEFI Causality Assessments: Is WHO eliminating vaccine-related deaths via subterfuge?
By Norma Erickson Altering AEFI Assessment Guidelines In April 2017, the World Health Organization (WHO) coordinated a joint project between teams of experts from the National AEFI (adverse events following immunization) committees of India and Zimbabwe with each country’s Ministry of Health. This project was titled an “Inter-country study to assess the inter-rater reliability of […]
Lessons learnt in Japan from adverse reactions to the HPV vaccine: a medical ethics perspective
Authors: Hirokuni Beppu, Masumi Minaguchi, Kiyoshi Uchide, Kunihiko Kumamoto, Masato Sekiguchi, Yukari Yaju Abstract: The human papillomavirus (HPV) vaccine has been linked to a number of serious adverse reactions. The range of symptoms is diverse and they develop in a multi-layered manner over an extended period of time. The argument for the safety and effectiveness of […]
Immunological studies of cerebrospinal fluid from patients with CNS symptoms after human papillomavirus vaccination
Immunological studies of cerebrospinal fluid from patients with CNS symptoms after human papillomavirus vaccination Highlights •32 patients with prolonged CNS symptoms after HPV vaccination were studied. •CSF levels of IL-4, IL-13, IL-17, IL-8 and MCP-1 were elevated. •CSF levels of PDGF-bb and IL-12 were decreased. •Antibodies to GluN2B-NT2, GluN2B-CT and GluN1-NT in CSF were increased. […]
- 1
- 2
- 3
- …
- 40
- Next Page »
